Merck Says Completes Enrolment Of Evobrutinib Phase III Clinical Trials

Reuters2021-10-04

Merck KGaA: Merck Completes Enrolment Of Evobrutinib Phase Iii Clinical Trials Ahead Of Ectrims 2021.Investigational Evobrutinib Is The First Bruton’S Tyrosine Kinase (Btk) Inhibitor To Complete Phase Iii Clinical Trial Enrolment In Relapsing Multiple Sclerosis (Rms).Data From Oral Presentations At Ectrims Show Evobrutinib Has A Positive Impact On Important Biomarkers Of Disease Progression.New Independent Data Also Presented Found That Patients Treated With Mavenclad® (Cladribine Tablets) Had Increased Antibody Igg Titer Levels Similar To That Of The General Population After A Complete Course Of An Mrna Covid-19 Vaccine.Further Company Coverage:. (Berlin Speed Desk).

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

dandan_4896
2021-10-04
dandan_4896
SGD 200 Stock Cash Coupon Bundle
CalvinYeo
2021-10-04
CalvinYeo
Do like, thanks
- dandan_4896:
  y
Adrian88
2021-10-04
Adrian88
Ok
- CalvinYeo:
  Done
arijit
2021-10-04
arijit
Better be cautious
- NoobZai:
  like
Mama123
2021-10-04
Mama123
Like and comment please
- Jl123456:
  OK
SteveTeo
2021-10-04
SteveTeo
great
- SteveTeo:
  ok
- VictorLin:
  Like
- Jellywonka:
  Ok

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2172998129?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-10-04 15:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2172998129","market":"us","top_or_hot":-1,"title":"Merck Says Completes Enrolment Of Evobrutinib Phase III Clinical Trials","media":"Reuters","content":"<p>Merck KGaA:&nbsp;Merck Completes Enrolment Of Evobrutinib Phase Iii Clinical Trials Ahead Of Ectrims 2021.Investigational Evobrutinib Is The First Bruton’S Tyrosine Kinase (Btk) Inhibitor To Complete Phase Iii Clinical Trial Enrolment In Relapsing Multiple Sclerosis (Rms).Data From Oral Presentations At Ectrims Show Evobrutinib Has A Positive Impact On Important Biomarkers Of Disease Progression.New Independent Data Also Presented Found That Patients Treated With Mavenclad® (Cladribine Tablets) Had Increased Antibody Igg Titer Levels Similar To That Of The General Population After A Complete Course Of An Mrna Covid-19 Vaccine.Further Company Coverage:. (Berlin Speed Desk). </p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck Says Completes Enrolment Of Evobrutinib Phase III Clinical Trials</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck Says Completes Enrolment Of Evobrutinib Phase III Clinical Trials\n</h2>\n\n<h4 class=\"meta\">\n\n2021-10-04 15:25 北京时间&nbsp;&nbsp;&nbsp;<strong>Reuters</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck KGaA: Merck Completes Enrolment Of Evobrutinib Phase Iii Clinical Trials Ahead Of Ectrims 2021.Investigational Evobrutinib Is The First Bruton’S Tyrosine Kinase (Btk) Inhibitor To Complete Phase...</p>\n\n<a href=\"None\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRK","symbol_name":"默沙东","start_time":0,"source_url":null,"article_id":"2172998129","we_media_id":"1086160438","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2172998129","pubTimestamp":1633332318,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"summary":"Merck KGaA: Merck Completes Enrolment Of Evobrutinib Phase Iii Clinical Trials Ahead Of Ectrims 2021","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRK":"默沙东"},"translate_title":"默沙东称埃沃鲁替尼III期临床试验完成注册","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRK":0.9},"content_text":"Merck KGaA: Merck Completes Enrolment Of Evobrutinib Phase Iii Clinical Trials Ahead Of Ectrims 2021.Investigational Evobrutinib Is The First Bruton’S Tyrosine Kinase (Btk) Inhibitor To Complete Phase Iii Clinical Trial Enrolment In Relapsing Multiple Sclerosis (Rms).Data From Oral Presentations At Ectrims Show Evobrutinib Has A Positive Impact On Important Biomarkers Of Disease Progression.New Independent Data Also Presented Found That Patients Treated With Mavenclad® (Cladribine Tablets) Had Increased Antibody Igg Titer Levels Similar To That Of The General Population After A Complete Course Of An Mrna Covid-19 Vaccine.Further Company Coverage:. (Berlin Speed Desk).","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":820932198,"gmtCreate":1633337885161,"gmtModify":1633337887795,"author":{"id":"3576232257279797","authorId":"3576232257279797","name":"dandan_4896","avatar":"https://static.tigerbbs.com/d8b00e27a4dd6f248e38c3d78f21f188","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"SGD 200 Stock Cash Coupon Bundle","listText":"SGD 200 Stock Cash Coupon Bundle","text":"SGD 200 Stock Cash Coupon Bundle","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820932198","repostId":2172998129,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":820996329,"gmtCreate":1633336002629,"gmtModify":1633336002970,"author":{"id":"3577186064735986","authorId":"3577186064735986","name":"CalvinYeo","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Do like, thanks","listText":"Do like, thanks","text":"Do like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/820996329","repostId":2172998129,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6087773,"gmtCreate":1633337894359,"gmtModify":1634722355225,"authorId":3576232257279797,"author":{"id":3576232257279797,"authorId":3576232257279797,"name":"dandan_4896","avatar":"https://static.tigerbbs.com/d8b00e27a4dd6f248e38c3d78f21f188","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":820996329,"type":1,"supId":0,"prevId":0,"content":"y","text":"y","html":"y"}],"langContent":"CN"},{"id":820990215,"gmtCreate":1633335473107,"gmtModify":1633335473244,"author":{"id":"4089878444731060","authorId":"4089878444731060","name":"Adrian88","avatar":"https://static.tigerbbs.com/e6c821844139b158ef20aa398c55abd1","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/820990215","repostId":2172998129,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6087593,"gmtCreate":1633336012688,"gmtModify":1634722366745,"authorId":3577186064735986,"author":{"id":3577186064735986,"authorId":3577186064735986,"name":"CalvinYeo","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":820990215,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"}],"langContent":"CN"},{"id":820077600,"gmtCreate":1633334091941,"gmtModify":1633334092226,"author":{"id":"3585027190392565","authorId":"3585027190392565","name":"arijit","avatar":"https://static.tigerbbs.com/61ad901d6d5ea07e5863e4477cf49f2a","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Better be cautious","listText":"Better be cautious","text":"Better be cautious","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/820077600","repostId":2172998129,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6087442,"gmtCreate":1633334752753,"gmtModify":1634722377299,"authorId":3586381108588721,"author":{"id":3586381108588721,"authorId":3586381108588721,"name":"NoobZai","avatar":"https://static.tigerbbs.com/11efd284456355c2f5498832e54042ff","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":820077600,"type":1,"supId":0,"prevId":0,"content":"like","text":"like","html":"like"}],"langContent":"CN"},{"id":820078184,"gmtCreate":1633333228212,"gmtModify":1633333228778,"author":{"id":"3581681339318837","authorId":"3581681339318837","name":"Mama123","avatar":"https://static.tigerbbs.com/e7f57802d09afb13f2149178c4f099b0","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Like and comment please","listText":"Like and comment please","text":"Like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/820078184","repostId":2172998129,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6087351,"gmtCreate":1633333763236,"gmtModify":1634722385460,"authorId":3581507104335566,"author":{"id":3581507104335566,"authorId":3581507104335566,"name":"Jl123456","avatar":"https://static.tigerbbs.com/e33617eb88bce300e61abe733e239b98","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":820078184,"type":1,"supId":0,"prevId":0,"content":"OK","text":"OK","html":"OK"}],"langContent":"CN"},{"id":820071876,"gmtCreate":1633333159367,"gmtModify":1633333159526,"author":{"id":"3577391264666074","authorId":"3577391264666074","name":"SteveTeo","avatar":"https://static.tigerbbs.com/a8447cdff8c551bee0792d0b5251d81f","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"great","listText":"great","text":"great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/820071876","repostId":2172998129,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6087312,"gmtCreate":1633333176636,"gmtModify":1634722388497,"authorId":3577391264666074,"author":{"id":3577391264666074,"authorId":3577391264666074,"name":"SteveTeo","avatar":"https://static.tigerbbs.com/a8447cdff8c551bee0792d0b5251d81f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":820071876,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":6087319,"gmtCreate":1633333226141,"gmtModify":1634722387845,"authorId":3561029602854131,"author":{"id":3561029602854131,"authorId":3561029602854131,"name":"VictorLin","avatar":"https://static.tigerbbs.com/8fd797c0a3e81d0a5a149ede57c53dc2","vip":1,"crmLevel":8,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":820071876,"type":1,"supId":0,"prevId":0,"content":"Like","text":"Like","html":"Like"},{"id":6087429,"gmtCreate":1633334683312,"gmtModify":1634722378606,"authorId":3570614147611531,"author":{"id":3570614147611531,"authorId":3570614147611531,"name":"Jellywonka","avatar":"https://static.tigerbbs.com/b9774fac6cdbae1bac77d81d9922fb02","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":820071876,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":45,"commentSize":9,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2172998129"}